CARBIOS reports solid H1 2025 results, regulatory support, and progress on PET biorecycling plant, with licensing and funding initiatives advancing.
CARBIOS has released its financial and operational results for the first half of 2025, reaffirming its commitment to developing a PET biorecycling plant in Longlaville and advancing the commercialization of its innovative technology. The Company reported a robust cash position of €72 million as of June 30, 2025, thanks to a disciplined and rigorously executed cost-saving plan. This strong liquidity provides a financial runway of more than twelve months, while CARBIOS continues its efforts to optimize operational expenses, reflecting a proactive approach to financial management.
Regulatory developments in France are set to support the Company’s growth trajectory. On September 7, 2025, the French government published a decree under the Environmental Code (Article L. 541-10-3) introducing financial incentives for the incorporation of recycled materials in products and discouraging the use of non-recyclable materials. This decree provides a bonus of €1,000 per ton for integrating biorecycled plastics derived from hard-to-recycle waste into sensitive-contact packaging, such as food packaging. With this regulatory support, CARBIOS can supply packaging clients in the French market with recycled PET (r-PET) that matches virgin PET in quality, transparency, and material properties, while remaining competitively priced. This positions the Company to process complex waste streams that are currently excluded from conventional recycling.
Construction of the Longlaville PET biorecycling plant is expected to resume before the end of 2025, subject to securing additional funding. Pre-sales of the plant’s future products are progressing, supported by favorable regulatory conditions. CARBIOS has secured a significant portion of its raw material supply and signed polymerization contracts, strengthening the industrial foundation of the project. The plant financing is expected to include €42.5 million in public funding, comprising a €30 million grant from ADEME and €12.5 million in regional aid approved under the European chemical recycling scheme, pending publication in the Official Journal of the European Union. Additional non-dilutive funding discussions are ongoing, with private investors expressing strong interest contingent on pre-sales of plant capacity. Two lead banks have been selected to drive these financing efforts. Leveraging the new French decree, CARBIOS aims to advance pre-sales to secure sufficient funding for the plant to resume construction by the end of 2025, with production targeted for the second half of 2027.
In parallel, CARBIOS continues to advance the commercialization of its technology through licensing agreements. With mature technology, comprehensive engineering documentation, and ongoing partner negotiations, the Company remains fully committed to its licensing strategy. CEO Vincent Kamel stated, “Our disciplined expense management, solid cash position, and recent favorable developments, both regulatory and industrial, give us confidence in executing our plan. We approach this next phase with determination, driven by client recognition of our technology’s value, the strength of our business model, and the commitment of our team.”
